Penserra Capital Management LLC

Position in TVTX — Travere Therapeutics, Inc.

CIK 1593324 ORINDA, CA

Position in TVTX

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$3,080,010

+$32,878 QoQ

Shares Held

54,216

-32.0% QoQ

Ownership

0.058%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#122

of 317 holders

Holding Since

Sep 2020

9 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Penserra Capital Management LLC holds $16,002,475 across 25 Biotechnology names. TVTX ranks #1 (19.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TVTX	Travere Therapeutics, Inc. This page	54,216	$3,080,010
2	AXSM	Axsome Therapeutics, Inc.	11,268	$2,758,068
3	TGTX	Tg Therapeutics, Inc.	50,017	$2,747,933
4	KRYS	Krystal Biotech, Inc.	5,142	$1,911,127
5	BCAX	Bicara Therapeutics Inc.	31,066	$922,349
6	ELVN	Enliven Therapeutics, Inc.	16,660	$845,495
7	APGE	Apogee Therapeutics, Inc.	6,300	$836,199
8	RCUS	Arcus Biosciences, Inc.	26,929	$830,221

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,080,010	54,216	-32.0%	Shares	Defined	2026-08-13
2025-12-31	$3,047,132	79,747	-1.0%	Shares	Defined	2026-02-12
2025-09-30	$1,925,288	80,556	-26.5%	Shares	Defined	2025-11-04
2025-03-31	$1,962,992	109,542	+7780.7%	Shares	Defined	2025-04-29
2021-09-30	$33,707	1,390	+1.1%	Shares	Defined	2021-11-15
2021-06-30	$20,061	1,375	+5.8%	Shares	Defined	2021-08-12
2021-03-31	$32,461	1,300	+11.1%	Shares	Defined	2021-05-13
2020-12-31	$31,888	1,170	—	Shares	Defined	2021-02-12
2020-09-30 RTRX	—	434	—	Shares	Defined	2020-11-13
No filing history on record for this holder in this stock.